欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号PT/H/2266/001
药品名称Flixonase Allergy 0.05% Nasal Spray
活性成分
    • fluticasone 0.05 %
剂型Nasal spray, suspension
上市许可持有人BEECHAM GROUP PLC
参考成员国 - 产品名称Portugal (PT)
互认成员国 - 产品名称
    • Denmark (DK)
    • Belgium (BE)
      Otrivine anti-allergie 50 microgrammes/dose suspension pour pulvérisation nasale
    • Netherlands (NL)
      Flixonase Allergy 0.05% neusspray
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Spain (ES)
    • Norway (NO)
    • Greece (GR)
      FLIXOTIDE ALLERGY®
    • Poland (PL)
      Flonase Allergy
    • Latvia (LV)
      Flixonase 50 mikrogrami/izsmidzinājumā deguna aerosols, suspensija
    • Lithuania (LT)
      Flixonase 50 mikrogramų/išpurškime nosies purškalas (suspensija)
    • Estonia (EE)
      Flixonase
    • Hungary (HU)
      FLIXONASE ALLERGIA 50 mikrogramm/adag szuszpenziós orrspray
    • Romania (RO)
      Flonase 50 micrograme/doza spray nazal, suspensie
    • Slovakia (SK)
      Flutikazónpropionát GSK 50 mikrogramov
    • Malta (MT)
      Flixonase Allergy 0.05% Nasal Spray
许可日期2015/04/22
最近更新日期2024/03/19
药物ATC编码
    • R01AD08 fluticasone
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase